SOLICITATION NOTICE
70 -- MoveIT Software Or Equal - Solicitation
- Notice Date
- 10/31/2016
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 511210
— Software Publishers
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-SOL-1176082
- Archive Date
- 11/23/2016
- Point of Contact
- Taye M Tebo, Phone: 240-402-7638
- E-Mail Address
-
Taye.Tebo@fda.hhs.gov
(Taye.Tebo@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Solicitation This is a Combined Synopsis/Solicitation for Commercial Items prepared in accordance with the format in FAR Subpart 12.6. This Request for Quotation (RFQ) announcement constitutes the only solicitation that will be issued; quotes are being requested and a written solicitation will not be issued. This requirement is being solicited as a small business set aside and the Government contemplates a Firm-Fixed Price Purchase Order will result from this solicitation. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 05-88-1 dated June 15, 2016. The associated North American Industrial Classification System (NAICS) code for this procurement is 511210. It’s associated Small Business Size Standard Size in millions of dollars $38.5. This requirement is a 100% total small business set-aside. 1.0 Introduction The Food and Drug Administration’s (FDA’s) mission is to enforce the Federal Food, Drug, and Cosmetic (FD&C) Act and other laws that are designed to protect consumers' health and safety. The Information Technology (IT) systems at the FDA were created to meet mission critical requirements and support requirements imposed by executive orders. These systems assist FDA personnel in tracking and managing cases throughout the regulatory workflow. The FDA Office of Information Management & Technology (OIMT) focuses on creating and maintaining IT environments for FDA applications that support the increasing need for information sharing and collaboration. Managing information consistently in this new environment plays a critical role in enabling the FDA’s efforts to transform agency operations and respond quickly and accurately to emerging scientific, technological, and economic trends affecting its regulatory mission. Prior to the centralization of OIMT, each center purchase software products with varying products and maintenance support. The goal of OIMT is to streamline and standardize software delivery and support services for software development efforts. Therefore, specific tools are needed to support consistency in the delivery of software. 2.0 Background FDA uses a variety of software to support the deployment and code transfers into the new data centers. MOVEit is used in the pre-production and production environments in Ashburn, Virginia (ADC). Currently data shares are used to move software from the development environment to the test environment and in some cases the production environment at the White Oak datacenter. This manual process introduces risk of losing data and not properly moving the data, as well as increases effort without establishing a versioning system to track what was moved and when. In the new data centers, access is restricted and monitored. This requires additional constraints on who has the authority to move data, data shares are adequately resourced and managed, and versions are tracked across the systems. Given the increase in risk to code integrity, FDA would like to track software transmissions consistently across the enterprise. MOVEit software allows FDA to lessen the burden of manually monitoring and tracking code transmissions and decrease the risk to code vulnerabilities. 3.0 Description and Schedule of Pricing The software renewal needs to include the following: (see attchedment for list) 4.0 Objective & Scope The purpose of this contract is to renew the license for maintenance and support for MOVEit to support the transfer of code from one environment to another and track historically what is transferred. The scope of this contract consists of procuring the renewal of maintenance and support of the MOVEit software and version upgrades. 5.0 Requirements MOVEit will be used to monitor code transfer and tracking. Specifically, the software tool shall be used to support existing systems that incorporate Oracle databases for critical systems at the FDA. The software shall allow the user access to all environments using one license key. 6.0 Salient Characteristics The Contractor shall provide maintenance and help desk/technical support to ensure the software licenses are functioning as expected. This includes: · Telephone access to technical expertise, Monday through Friday, from 9 – 5 ET. Technical support shall be available either on-line or by telephone. · An account manager to assist with the specific account · Requirements tracking to track any issues that are identified · Upgrades as patches and new versions of the software become available · Access to software and upgrades via the internet · Access to user guides and technical specification via the internet · The tools and license support must also include user support services and the capacity to add users without change in functionality. The Contractor shall provide timely notification of new releases of all tools and provide all updated software, documentation, and training materials in addition to specific management and administrative requirements described. All software keys and other associated deliverables shall be provided to the FDA in electronic form for installation and maintenance. · Escalation procedures that may require on-site Contractor assistance shall be at no cost to the Government. 7.0 Deliverables The FDA is shall provide unlimited license and maintenance of MOVEit as specified in 3.0 Description and Schedule of Pricing 8.0 Inspection and Acceptance The COR will perform inspection and acceptance of all products and services. The performance criteria for these products shall be timely delivery and closure of all activities and deliverables listed above and within the established Period of Performance. 9.0 Period of Performance The period of performance shall be from November 15, 2016 through November 14, 2017 10.0 Place of Performance Contractor Location 11.0 Contracting Officer’s Representative (COR) The COR will be designated by the Contracting Officer at award. 12.0 Authorized Contractor The Contractor shall be the software Original Equipment Manufacturer (OEM) or an authorized reseller/servicing agent of the software OEM. The Contractor shall not void any warranties, usage terms and conditions of the FDA's perpetual licenses. The Contractor shall notify the Contract Specialist / Contracting Officer immediately if this requirement is registered by a reseller with the OEM. 13.0 Clauses The below Health and Human Services Acquisition Regulation (HHSAR) Clauses apply. HHSAR Clauses can be viewed in full text at: http://www.hhs.gov/policies/hhsar/subpart352.html#subpart352.1 -- InstructionsforUsingProvisionsandClauses 352.203-70 - Anti-Lobbying (DEC 2015) 352.222-70 - Contractor Cooperation in Equal Employment Opportunity Investigations (DEC 2015) 352.239-74 - Electronic Information and Technology Accessibility (DEC 2015) The below Federal Acquisition Regulation (FAR) Clauses apply. FAR Clauses can be viewed in full text at: http://www.acquisition.gov/far/current/html/FARTOCP52.html#wp372482 52.212-4 -- Contract Terms and Conditions -- Commercial Items (May 2015) 52.227-19 - Commercial Computer Software License (Dec 2007) 52.232-39 - Unenforceability of Unauthorized Obligations (Jun 2013) 52.232-40 -- Providing Accelerated Payment to Small Business Subcontractors (Dec 2013) 14.0 Invoicing The following personnel will represent the Government for the purpose of this contract: FDA Invoice Requirements: FDA THREE-WAY-MATCHING INVOICE CLAUSE A. THE CONTRACTOR SHALL SUBMIT ONE (1) ORIGINAL COPY OF EACH INVOICE TO THE ADDRESS SPECIFIED BELOW: Office of Financial Services Food and Drug Administration 10903 New Hampshire Ave WO32 - Second Floor MAIL HUB 2145 Silver Spring, MD 20993-0002 Attn: Vendor Payments 301.827.3742 or 866.807.3742 fdavendorpaymentsteam@fda.gov B. Invoices submitted under this contract must comply with the requirements set forth in FAR Clauses 52.232-25 (Prompt Payment) and 52.232-33 (Payment by Electronic Funds Transfer / System for Award Management) and/or other applicable FAR clauses specified herein. To constitute a proper invoice, the invoice must be submitted on company letterhead and include each of the following: (I) Name and address of the contractor; (ii) Invoice date and invoice number; (iii) Purchase order/award number; (iv) Description, quantity, unit of measure, unit price, and extended price supplies delivered or services performed, including: (a) period of performance for which costs are claimed; (b) itemized travel costs, including origin and destination; (c) any other supporting information necessary to clarify questionable expenditures; (d) The contractor shall include the Contract Line Item/Funding line item number for each description, quantity, unit of measure, unit price, and extended price supplies delivered or services performed (v) Shipping number and date of shipment, including the bill of lading number and weight of shipment if shipped on government bill of lading; (vi) Terms of any discount for prompt payment offered; (vii) Name and address of official to whom payment is to be sent (must be the same as that in the purchase order/award, or in a proper notice of assignment); (viii) Name, title, and phone number of person to notify in event of defective invoice; (ix) Taxpayer identification number (TIN); (x) Electronic funds transfer (EFT) banking information, including routing transit number of the financial institution receiving payment (xi) Name and telephone number of the FDA Contracting Officer (CO) and the Contracting Officer's Representative (COR) or other program center/office point of contact, as referenced on the order/contract; (xii) Any other information or documentation required by the purchase order/award. C. An electronic invoice shall be in adobe acrobat (PDF) format. All items listed in (i) through (xii) of this clause must be included in the electronic invoice. Electronic invoices must be on company letterhead and must contain no ink changes and be legible for printing. D. Questions regarding invoice payments should be directed to the FDA Payment Office at: Food and Drug Administration/ Office of Financial Services, 10903 New Hampshire Ave WO32 - Second Floor, MAIL HUB 2145 Silver Spring, MD 20993-0002 Attn: Vendor Payments Phone 301-827-ERIC (3742) 15.0 Section 508 Compliance Requirements Section 508 of the Rehabilitation Act of 1973 (29 U.S.C. 794d) requires Federal agencies to purchase electronic and information technologies (EIT) that meet specific accessibility standards. This law helps to ensure that federal employees with disabilities have access to, and use of, the information and data they need to do their jobs. Furthermore, this law ensures that members of the public with disabilities have the ability to access government information and services. There are three regulations addressing the requirements detailed in Section 508. The Section 508 technical and functional standards are codified at 36 CFR Part 1194 and may be accessed through the Access Board's Web site at http://www.access-board.gov. The second regulation issued to implement Section 508 is the Federal Acquisition Regulation (FAR). FAR Part 39.2 requires that agency acquisitions of Electronic and Information Technology (EIT) comply with the Access Board's standards. The entire FAR is found at Chapter 1 of the Code of Federal Register (CFR) Title 48, located at http://www.acquisition.gov. The FAR rule implementing Section 508 can be found at http://www.section508.gov. The third applicable regulation is the HHS Acquisition Regulation (HHSAR). Regardless of format, all Web content or communications materials produced for publication on or delivery via HHS Web sites - including text, audio or video - must conform to applicable Section 508 standards to allow federal employees and members of the public with disabilities to access information that is comparable to information provided to persons without disabilities. All contractors (including subcontractors) or consultants responsible for preparing or posting content intended for use on an HHS-funded or HHS-managed Web site must comply with applicable Section 508 accessibility standards, and where applicable, those set forth in the referenced policy or standards documents below. Remediation of any materials that do not comply with the applicable provisions of 36 CFR Part 1194 as set forth in the SOW, shall be the responsibility of the contractor or consultant retained to produce the Web-suitable content or communications material. Unless an agency exception to this requirement exists, the Contractor must conform to applicable Section 508 standards and must apply best practices associated with Section 508 compliance during the application design, development, and testing phases. The Contractor shall utilize FDA approved tools to verify the compliance with the Section 508 standards and ensure the delivery of the fully compliant products. The following Section 508 provisions apply to the content identified in this SOW: § 1194.21 - Software applications and operating systems § 1194.22 - Web-based intranet and internet information and applications § 1194.41 - Information, documentation, and support 16.0 Order of Precedence The Contractor shall following the terms and conditions of this order. Should the Contractor include any additional terms and conditions resulting in conflicts between this document and the Contractor's document, the Order of Precedence shall be as specified in FAR Clause 52.212-4, dated May 2015. Any governing law language appearing in any Contractor terms or conditions shall be treated as null, void and stricken. Any additional terms and conditions identified with a web link and/or incorporated by reference shall be stricken and removed from this order (not the Schedule). The Contractor shall provide all terms and conditions with their quotations as attachments, appendixes, etc. In the event of any inconsistencies between any licensing agreement incorporated into this order as an attachment and the FAR and HHSAR Clauses incorporated into this order, the FAR or HHSAR Clauses shall take precedence. 17.0 Instructions to Quoters Provisions: 352.239-73 - Electronic Information and Technology Accessibility Notice (DEC 2015) 52.211-6 - Brand Name or Equal (Aug 1999) Quoter shall certify their quotes to be valid for 60 days Incomplete pricing or pricing with omissions may not be considered for award. All quotes will be evaluated on a Lowest Priced Technically Acceptable (LPTA) basis. FDA anticipates that this contract will be firm fixed price. Quoters shall submit one (1) copy of their quotation with pricing information. Equal to quotes must meet all the salient characteristics in order to be considered technically acceptable. If the part numbers are different from the vendors' part numbers, Quoters shall map their part numbers to the vendor's part numbers. Compatibility: FDA is purchasing this equipment on a "Brand Name or Equal" basis. In order to be considered an “equal" solution, an alternative solution must be compatible with the equipment already owned by FDA.Maintenance provided shall not void any warranties, usage terms and conditions of the FDA's perpetual licenses. For the purposes of this RFQ, FDA defines compatible as meaning that there will be no communication, performance, maintainability issues in the interconnection of solutions with different configurations. Equal to quotes must submit a separate Technical quote with detailed point-by-point description of how the equal to product meets all the salient characteristics of this SOW. Quotes with the specified Oracle Software license and maintenance service meeting all the salient characteristics of this SOW is not required to submit a separate Technical Quote. Technical quotes shall not contain pricing information. All Quoters providing quotations must clearly state the overall cost to the Government. Quoters shall submit all applicable terms and conditions in full text as attachments, appendix, or exhibits. Quoters shall submit Product Accessibility Templates (PAT) in full text with their quotations. Quoters providing quotations must clearly state the overall cost to the Government. Quoters shall submit all assumptions in their quotation. The Quoter shall notify the Contract Specialist / Contracting Officer immediately if this requirement is registered by a reseller with the Original Equipment Manufacturer (OEM). Quoters are advised that additional terms and conditions submitted with their quotation that is in conflict of the terms and conditions of this solicitation may be deemed as technically unacceptable and as such not be considered for award. Quoters shall submit the terms and conditions in full text with their quote. Quoters are advised to provide their best prices in their quotation. The Government does not intend to have communications to allow revision of the quotation. But the Government reserves the right to communicate with Quoters should the Government determined it is necessary for quotation revisions prior to award. 18.0 Award Determination All quotations will be evaluated on a Lowest Priced Technically Acceptable (LPTA) basis. The award will be made to the lowest price quoter that demonstrates they can meet all the requirements of this solicitation. Failure to demonstrate meeting any of the requirements will result in a rating of technically unacceptable and will not be considered for award. Incomplete quotation will not be considered for award.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-SOL-1176082/listing.html)
- Place of Performance
- Address: Contractor Location, United States
- Record
- SN04316772-W 20161102/161031234626-684a281b5bafa56a3c89102d9014282c (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |